The cost of Xiidra can vary based on insurance coverage, pharmacy, and whether a discount program is applied. Without insurance, a 30-day supply of Xiidra can cost several hundred dollars. For instance, one source indicates a retail price of approximately $592 for a 90-day supply [1].
Can I get a discount on Xiidra?
Yes, there are savings programs available for Xiidra. Patients with commercial insurance may be eligible for a savings card, which can reduce their out-of-pocket costs. Some programs allow eligible patients to pay as little as $0 for their prescription for up to 12 months [2]. These programs typically have terms and conditions, and eligibility may depend on insurance status [2].
How does Xiidra compare to other dry eye treatments in terms of cost?
The cost of Xiidra is comparable to other prescription treatments for dry eye disease. Many prescription eye drops used to manage dry eye symptoms have similar price points, especially when considering out-of-pocket expenses without significant insurance coverage or discounts. The overall cost of managing dry eye also includes potential visits to eye care professionals and other supportive therapies.
What is the typical cash price for Xiidra?
The cash price for Xiidra without insurance is substantial. As an example, a 30-day supply can cost upwards of $200, and a 90-day supply can exceed $500 [1]. These prices reflect the cost of the medication itself, without any adjustments for insurance benefits or manufacturer savings programs.
When does Xiidra's patent expire?
Understanding Xiidra's patent status is important for potential cost changes or the introduction of generic alternatives. Information regarding the specific patent expiry dates for Xiidra can be found through resources like DrugPatentWatch.com [3]. Patent expiration is a key factor in the availability and pricing of generic versions of medications.
Who makes Xiidra?
Xiidra was developed by Takeda Pharmaceutical Company [4]. Takeda acquired the rights to Xiidra from its original developer, Shire, in 2019 [4].
What is the active ingredient in Xiidra and what does it do?
The active ingredient in Xiidra is lifitegrast [5]. Lifitegrast is a small molecule drug that works by blocking the interaction of two proteins, LFA-1 and ICAM-1 [5]. This interaction is believed to contribute to the inflammation associated with dry eye disease [5]. By inhibiting this interaction, lifitegrast helps to reduce inflammation, which can improve the signs and symptoms of dry eye [5].
How is Xiidra administered and what is the dosage?
Xiidra is an ophthalmic solution that is administered as eye drops. The typical dosage is one drop in each eye twice daily, approximately 12 hours apart [6]. It is important to follow the prescribing doctor's instructions for use.
What clinical trials have been conducted for Xiidra?
Xiidra has undergone clinical trials to evaluate its safety and efficacy in treating dry eye disease. These trials have assessed its impact on both the signs and symptoms of the condition. Information about specific clinical trials, including their design and outcomes, can often be found in drug approval documents or scientific literature databases.
What are the potential side effects of Xiidra?
Common side effects of Xiidra can include instillation site reactions, such as burning or stinging upon instillation, and changes in taste, such as dysgeusia [5]. Other reported side effects may include blurred vision and eye irritation [5]. Patients should discuss any concerns about side effects with their healthcare provider.
What are the recommended storage conditions for Xiidra?
Xiidra should be stored at room temperature, between 20°C to 25°C (68°F to 77°F) [7]. It is important to keep the bottle tightly closed when not in use and to discard any unused solution after 50 days from opening [7].
Can Xiidra be used concurrently with other dry eye treatments?
Patients should consult their doctor regarding the concurrent use of Xiidra with other ophthalmic medications. While some combination therapies are common in managing dry eye, it is essential to have professional guidance to ensure safety and efficacy, and to avoid potential interactions.
---
Sources:
[1] https://www.goodrx.com/xiidra
[2] https://www.xiidra.com/savings-and-support/
[3] https://drugpatentwatch.com/
[4] https://www.takeda.com/newsroom/news/2019/takeda-completes-acquisition-of-shire-creating-a-leading-global-patient-focused-pharma-company/
[5] https://www.xiidra.com/about-xiidra/
[6] https://www.xiidra.com/how-to-use/
[7] https://www.rxlist.com/xiidra-drug-article.htm